The San Diego–based company has also submitted for an FDA 510(k) for G7 and awaits clearance in the U.S.
Dexcom designed its next-generation CGM offering as an all-in-one wearable system. It warms up in 30 minutes — compared to two hours with the previous G6 generation — and sends real-time glucose readings automatically to a compatible smart device or receiver with no fingersticks required.
Get the full story at our sister site, Drug Delivery Business News.